Seres-013: Ecospor Iv: An Open-Label Extension Of Study Seres-012 And Open-Label Program For Evaluating Ser-109 In Adult Subjects With Recurrent Clostridioides Difficile Infection (Rcdi)
Posted Date: Sep 21, 2021
- Investigator: Loren Brook
- Specialties:
- Type of Study: Drug
An Open-Label study for evaluating SER-109 in adult subjects with recurrent Clostridioides difficile infection.
Criteria:
Positive Clostridioides Difficile Test. Able And Willing To Sign Consent And Comply With Study-Specific Procedure Or Treatment.
Keywords:
C. Diff, Clostridium Difficile, Recurrent
For More Information:
Missy Randolph
15135585529
randollj@ucmail.uc.edu